国际喘死亡率趋势:来自46个国家的世卫组织死亡数据库数据分析 (1993-2012)
Stefan Ebmeier1, Darmiga Thayabaran1, Irene Braithwaite1
1Medical Research Institute of New Zealand, Wellington, New Zealand.
Lancet (London, England)
|August 12, 2017
概括
全球喘死亡率几十年来一直在下降, 进一步减少喘死亡需要改进管理策略和新的方法.
科学领域:
- 肺部医学
- 流行病学
- 全球健康
背景情况:
- 国际喘死亡率趋势受到管理和药物治疗的影响.
- 在过去的十年里, 喘死亡率的趋势在很大程度上是未知的.
- 这项研究调查了最近的国际喘死亡率模式.
研究的目的:
- 评估过去十年喘死亡率的全球趋势.
- 分析不同收入国家的喘死亡率变化.
- 确定之前观察到的喘死亡减少的潜在延迟.
主要方法:
- 从世卫组织死亡数据库 (1993-2012) 收集了46个国家的年龄标准化喘死亡率 (5-34岁).
- 包括至少有10年的完整数据的国家.
- 使用按国家人口加权的局部加权分散图 (LOESS) 曲线来可视化全球趋势.
主要成果:
- 分析包括36个高收入国家和10个中等收入国家.
- 全球喘死亡率从1993年的0.44/100,000下降到2006年的0.19/100,000.
- 在2006年至2012年期间,全球喘死亡率没有显著变化 (率保持在0. 19/100,000).
结论:
- 自20世纪80年代末以来, 全球喘死亡率的下降趋势可能已经停滞不前.
- 在2006年至2012年期间,喘死亡率没有显著降低.
- 为了实现进一步的减排,需要更好地实施当前的战略,并开发新的方法.
相关概念视频
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-IV: Nursing Management
3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.9K


